Recent Updates
Recently added Catalysts

Biotech Stock Screener

Filter 1,000+ biotech companies by clinical trial phase, therapeutic area, cash runway, market cap, and upcoming FDA catalysts to find your next high-conviction idea.
Showing 6 Company Out Of 1076. Click On The Tickers For More Details
Ticker Name Price 30-Day Trend Pipeline Segment Valuation Therapeutic Area Market Capital Volume P/E RATIO Insiders EPS D/E RATIO Live-Cash Burn Rate Ebitda Runway Risk
A
Agilent Technologies, Inc.
131.62 -2.30 %
N/A (Dx)
Diagnostics
Diagnostics
38.14 B

1.99 M

27.12

-3.27 M

5.00

0.49

1.81 B

116.33 M

1.84 B

15.11

PROFITABLE
AAPG
Ascentage Pharma Group International - American Depository Shares
17.07 -0.29 %
C
54 APG-115 (Phase 2)
Pharma Commercial
Overvalued
1.97 B

2.57 K

0.00

-

-1.94

1.50

171.93 M

14.56 M

-156.72 M

24.28

—
AARD
Aardvark Therapeutics, Inc.
3.48 -2.79 %
C
43 ARD-101 (Phase 2)
Pharma Commercial
Fair Value
99.05 M

104.75 K

0.00

-

-3.21

0.00

91.20 M

6.29 M

-74.68 M

13.40

STABLE
ABBV
AbbVie Inc.
224.95 -0.27 %
A
92 MGd (Phase 3)
Pharma Commercial
Fair Value
380.57 B

4.15 M

106.24

-2.84 M

2.03

0.00

9.39 B

1.77 B

29.19 B

5.31

PROFITABLE
ABCL
AbCellera Biologics Inc.
5.09 -4.72 %
D
34 ABCL575 (Phase 1)
Biotech Commercial
Richly Valued
1.87 B

3.75 M

-12.78

95.40 K

-0.48

0.15

504.73 M

11.17 M

-181.09 M

44.20

HEALTHY
ABEO
Abeona Therapeutics Inc.
5.36 -1.65 %
C
51 ofloxacin (Phase 3)
Pharma Commercial
Fair Value
324.30 M

1.01 M

6.07

-2.06 M

1.30

0.16

168.27 M

6.60 M

-89.14 M

24.60

HEALTHY
API Access

Simple Pricing, Powerful Insights

Full access to Biotech/Pharma investing and trading opportunities.

No hidden fees, powerful insights, tools, and exclusive real time data to maximize your biotech profits.

yearly_arrow
For Serious Investor and Traders
Recommended

Your Key to Consistent Profits: Save Big with Our Annual Plan at Just $19.00 per Month

Only $19.00/ Month

  • Searchable FDA calendar providing data readouts and PDUFA
  • Full access to drug pipelines and company health for informed decisions
  • Download all the data in Excel sheet
  • Track biotech earnings and catalyst events
  • Monitor insider trading and hedge fund holdings
  • Advanced portfolio management tools
  • Research on over 1,100 companies and clinical trials
  • Get real-time market updates
  • Learn with exclusive courses
View Details
For Visitors

Preview only and discover why serious investors choose our Premium Plan for comprehensive data.

$0.00 / Month

  • Includes 3 day Elite access
For Serious Investor and Traders
Recommended

Your Key to Consistent Profits: Save Big with Our Annual Plan at Just $19.00 per Month

Only $19.00/ Month

  • Searchable FDA Calendar with 1000+ catalysts like clinical readouts and PDUFA
  • Full access to drug pipelines and company health for informed decisions
  • Probability of Approval (PoA) score cards for each asset
  • Download all data in Excel for your models
  • Historical FDA decisions to shape strategic plans
  • Track biotech earnings and critical catalyst events
  • Monitor insider trading and hedge fund holdings for market insights
  • Options flow and strategy modules (screeners and playbooks)
  • Advanced portfolio tools for smart biotech investments
  • Research on 1,100+ companies and clinical trials
  • Real-time market updates, trends, and analysis
  • Live news feed with customizable alerts (tickers, drugs, indications)
  • Exclusive courses on biotech investment basics
View Details